Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_25041 | 396 | 8.25 | Mlig455_062863, Mlig455_062947, Mlig455_067045, Mlig455_067086 | Neo: - Age: - |
BCAR1 | Mlig455_062863 {REF} {Length: 3844} {Pfam: Serine rich protein interaction domain [PF08824.12, score=73.3]; Variant SH3 domain [PF07653.19, score=30.8]; SH3 domain [PF00018.30, score=28.8]; Variant SH3 domain [PF14604.8, score=26.7]} {Human: ENSG00000050820, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]; ENSG00000285460, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]} {Mouse: ENSMUSG00000031955, Bcar1, breast cancer anti-estrogen resistance 1, [RH, Score=84.0, Expect=4e-16]; ENSMUSG00000021365, Nedd9, neural precursor cell expressed, developmentally down-regulated gene 9, [RH, Score=80.1, Expect=5e-15]} {Dmel: FBgn0035101, p130CAS, [RH, Score=80.1, Expect=4e-15]} {Smed: dd_Smed_v6_6476_0_1, dd_Smed_v6_6476_0_1, [RH, Score=85.5, Expect=3e-17]} {RNA1509_20874} {RNA1310_4620} {RNA815_10909} Mlig455_062947 {REF} {Length: 1452} {Pfam: SH3 domain [PF00018.30, score=23.3]} {Human: ENSG00000050820, BCAR1, BCAR1, Cas family scaffold protein, [Score=56.6, Expect=2e-09]; ENSG00000285460, BCAR1, BCAR1, Cas family scaffold protein, [Score=56.6, Expect=2e-09]} {Mouse: ENSMUSG00000031955, Bcar1, breast cancer anti-estrogen resistance 1, [Score=54.3, Expect=7e-09]} {Dmel: FBgn0035101, p130CAS, [Score=53.1, Expect=1e-08]} {RNA1509_20874} {RNA1310_4620} {RNA815_57349} Mlig455_067045 {REF} {Length: 3571} {Pfam: Serine rich protein interaction domain [PF08824.12, score=73.3]; Variant SH3 domain [PF07653.19, score=30.8]; SH3 domain [PF00018.30, score=28.8]; Variant SH3 domain [PF14604.8, score=26.7]} {Human: ENSG00000285460, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]; ENSG00000050820, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]} {Mouse: ENSMUSG00000031955, Bcar1, breast cancer anti-estrogen resistance 1, [RH, Score=84.0, Expect=4e-16]; ENSMUSG00000021365, Nedd9, neural precursor cell expressed, developmentally down-regulated gene 9, [RH, Score=80.5, Expect=5e-15]} {Dmel: FBgn0035101, p130CAS, [RH, Score=80.1, Expect=4e-15]} {Smed: dd_Smed_v6_6476_0_1, dd_Smed_v6_6476_0_1, [RH, Score=85.5, Expect=4e-17]} {RNA1509_20874} {RNA1310_4620, RNA1509_20874} {RNA1509_20874, RNA815_10909} Mlig455_067086 {REF} {Length: 3280} {Pfam: Serine rich protein interaction domain [PF08824.12, score=73.4]; Variant SH3 domain [PF07653.19, score=30.8]; SH3 domain [PF00018.30, score=28.8]; Variant SH3 domain [PF14604.8, score=26.7]} {Human: ENSG00000285460, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]; ENSG00000050820, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]} {Mouse: ENSMUSG00000031955, Bcar1, breast cancer anti-estrogen resistance 1, [RH, Score=84.0, Expect=3e-16]; ENSMUSG00000021365, Nedd9, neural precursor cell expressed, developmentally down-regulated gene 9, [RH, Score=80.5, Expect=4e-15]} {Dmel: FBgn0035101, p130CAS, [RH, Score=80.5, Expect=3e-15]} {Smed: dd_Smed_v6_6476_0_1, dd_Smed_v6_6476_0_1, [RH, Score=85.5, Expect=3e-17]} {RNA1509_20874} {RNA1310_4620} {RNA815_10909} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.512 | 3.539 | 0.17281 | 0.79854 | |
RegionR2 | 1.346 | 3.539 | 0.06267 | 0.30209 | |
RegionR3 | 0.183 | 3.539 | 0.79277 | 1.00000 | |
RegionR4 | 1.708 | 3.539 | 0.01979 | 0.10140 | |
RegionR5 | -0.598 | 3.539 | 0.74791 | 1.00000 | |
RegionR6 | 1.521 | 3.539 | 0.01316 | 0.19906 | |
RegionR7 | 0.723 | 3.539 | 0.40577 | 1.00000 | |
RegionR8 | -0.371 | 3.539 | 0.86090 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.124 | 3.539 | 0.99880 | 1.00000 | |
RegenerationR2 | -0.285 | 3.539 | 0.51569 | 0.87814 | |
RegenerationR3 | 1.58 | 3.539 | 0.00347 | 0.10476 | |
RegenerationR4 | -0.59 | 3.539 | 0.28687 | 0.73163 | |
RegenerationR5 | 1.581 | 3.539 | 0.00422 | 0.11684 | |
RegenerationR6 | -0.9 | 3.539 | 0.09629 | 0.38599 | |
RegenerationBL | -1.988 | 3.539 | 0.03285 | 0.20337 | |
RegenerationTP | 1.304 | 3.539 | 0.06315 | 0.40709 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_25041 | 396 | 8.25 | Mlig455_062863, Mlig455_062947, Mlig455_067045, Mlig455_067086 | Neo: - Age: - |
BCAR1 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_062863 {REF} {Length: 3844} {Pfam: Serine rich protein interaction domain [PF08824.12, score=73.3]; Variant SH3 domain [PF07653.19, score=30.8]; SH3 domain [PF00018.30, score=28.8]; Variant SH3 domain [PF14604.8, score=26.7]} {Human: ENSG00000050820, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]; ENSG00000285460, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]} {Mouse: ENSMUSG00000031955, Bcar1, breast cancer anti-estrogen resistance 1, [RH, Score=84.0, Expect=4e-16]; ENSMUSG00000021365, Nedd9, neural precursor cell expressed, developmentally down-regulated gene 9, [RH, Score=80.1, Expect=5e-15]} {Dmel: FBgn0035101, p130CAS, [RH, Score=80.1, Expect=4e-15]} {Smed: dd_Smed_v6_6476_0_1, dd_Smed_v6_6476_0_1, [RH, Score=85.5, Expect=3e-17]} {RNA1509_20874} {RNA1310_4620} {RNA815_10909} Mlig455_062947 {REF} {Length: 1452} {Pfam: SH3 domain [PF00018.30, score=23.3]} {Human: ENSG00000050820, BCAR1, BCAR1, Cas family scaffold protein, [Score=56.6, Expect=2e-09]; ENSG00000285460, BCAR1, BCAR1, Cas family scaffold protein, [Score=56.6, Expect=2e-09]} {Mouse: ENSMUSG00000031955, Bcar1, breast cancer anti-estrogen resistance 1, [Score=54.3, Expect=7e-09]} {Dmel: FBgn0035101, p130CAS, [Score=53.1, Expect=1e-08]} {RNA1509_20874} {RNA1310_4620} {RNA815_57349} Mlig455_067045 {REF} {Length: 3571} {Pfam: Serine rich protein interaction domain [PF08824.12, score=73.3]; Variant SH3 domain [PF07653.19, score=30.8]; SH3 domain [PF00018.30, score=28.8]; Variant SH3 domain [PF14604.8, score=26.7]} {Human: ENSG00000285460, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]; ENSG00000050820, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]} {Mouse: ENSMUSG00000031955, Bcar1, breast cancer anti-estrogen resistance 1, [RH, Score=84.0, Expect=4e-16]; ENSMUSG00000021365, Nedd9, neural precursor cell expressed, developmentally down-regulated gene 9, [RH, Score=80.5, Expect=5e-15]} {Dmel: FBgn0035101, p130CAS, [RH, Score=80.1, Expect=4e-15]} {Smed: dd_Smed_v6_6476_0_1, dd_Smed_v6_6476_0_1, [RH, Score=85.5, Expect=4e-17]} {RNA1509_20874} {RNA1310_4620, RNA1509_20874} {RNA1509_20874, RNA815_10909} Mlig455_067086 {REF} {Length: 3280} {Pfam: Serine rich protein interaction domain [PF08824.12, score=73.4]; Variant SH3 domain [PF07653.19, score=30.8]; SH3 domain [PF00018.30, score=28.8]; Variant SH3 domain [PF14604.8, score=26.7]} {Human: ENSG00000285460, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]; ENSG00000050820, BCAR1, BCAR1, Cas family scaffold protein, [RH, Score=85.9, Expect=1e-16]} {Mouse: ENSMUSG00000031955, Bcar1, breast cancer anti-estrogen resistance 1, [RH, Score=84.0, Expect=3e-16]; ENSMUSG00000021365, Nedd9, neural precursor cell expressed, developmentally down-regulated gene 9, [RH, Score=80.5, Expect=4e-15]} {Dmel: FBgn0035101, p130CAS, [RH, Score=80.5, Expect=3e-15]} {Smed: dd_Smed_v6_6476_0_1, dd_Smed_v6_6476_0_1, [RH, Score=85.5, Expect=3e-17]} {RNA1509_20874} {RNA1310_4620} {RNA815_10909} |
2. | MligTC455_25040 | 129 | 2.7 | Mlig455_062946 | Neo: - Age: - |
5.96 | 0.993 | 0.999 | 0.979 | 0.996 | 0.995 | 0.998 | Mlig455_062946 {REF} {Length: 1957} {Pfam: Serine rich protein interaction domain [PF08824.12, score=41.4]} {Smed: dd_Smed_v6_6476_0_1, dd_Smed_v6_6476_0_1, [Score=65.9, Expect=2e-12]} {RNA1509_20874} {RNA1310_4620} {RNA815_10909} | |
3. | MligTC455_20529 | 56 | 1.18 | Mlig455_005302 | Neo: - |
1.779 | - | - | - | - | 0.954 | 0.825 | Mlig455_005302 {REF} {Length: 1691} {RNA1509_3030} {RNA1310_35103} {RNA815_26539} | |
4. | MligTC455_28562 | 165 | 3.44 | Mlig455_042324, Mlig455_047105 | Neo: - Age: - |
INPP1 | 1.654 | - | - | 0.700 | - | 0.954 | - | Mlig455_042324 {REF} {Length: 2884} {Pfam: Inositol monophosphatase family [PF00459.27, score=115.6]} {Human: ENSG00000151689, INPP1, inositol polyphosphate-1-phosphatase, [RH, Score=270, Expect=6e-87]} {Mouse: ENSMUSG00000026102, Inpp1, inositol polyphosphate-1-phosphatase, [RH, Score=305, Expect=1e-100]} {Dmel: FBgn0016672, Ipp, Inositol polyphosphate 1-phosphatase, [RH, Score=243, Expect=3e-77]} {Celegans: WBGene00044063, bpnt-1, 3'(2'), 5'-BisPhosphate NucleoTidase 1 homolog, [Score=76.3, Expect=3e-15]} {Smed: dd_Smed_v6_9612_0_1, dd_Smed_v6_9612_0_1, [Score=182, Expect=1e-53]} {RNA1509_47975} {RNA1310_24152, RNA1509_47975} {RNA1509_47975, RNA815_18809} Mlig455_047105 {REF} {Length: 2512} {Pfam: Inositol monophosphatase family [PF00459.27, score=115.6]} {Human: ENSG00000151689, INPP1, inositol polyphosphate-1-phosphatase, [RH, Score=270, Expect=6e-87]} {Mouse: ENSMUSG00000026102, Inpp1, inositol polyphosphate-1-phosphatase, [RH, Score=305, Expect=1e-100]} {Dmel: FBgn0016672, Ipp, Inositol polyphosphate 1-phosphatase, [RH, Score=243, Expect=3e-77]} {Celegans: WBGene00044063, bpnt-1, 3'(2'), 5'-BisPhosphate NucleoTidase 1 homolog, [Score=76.3, Expect=3e-15]} {Smed: dd_Smed_v6_9612_0_1, dd_Smed_v6_9612_0_1, [Score=182, Expect=1e-53]} {RNA1509_47975} {RNA1310_24152} {RNA815_18809} |
5. | MligTC455_18347 | 118 | 2.46 | Mlig455_000821 | Neo: - |
KCNA1 | 0.975 | - | - | 0.975 | - | - | - | Mlig455_000821 {REF} {Length: 3163} {Pfam: Ion transport protein [PF00520.33, score=166.1]; BTB/POZ domain [PF02214.24, score=97.8]; Ion channel [PF07885.18, score=48.4]} {Human: ENSG00000111262, KCNA1, potassium voltage-gated channel subfamily A member 1, [RH, Score=611, Expect=0.0]; ENSG00000177301, KCNA2, potassium voltage-gated channel subfamily A member 2, [RH, Score=611, Expect=0.0]; ENSG00000177272, KCNA3, potassium voltage-gated channel subfamily A member 3, [RH, Score=610, Expect=0.0]; ENSG00000182255, KCNA4, potassium voltage-gated channel subfamily A member 4, [RH, Score=585, Expect=0.0]} {Mouse: ENSMUSG00000040724, Kcna2, potassium voltage-gated channel, shaker-related subfamily, member 2, [RH, Score=611, Expect=0.0]; ENSMUSG00000047976, Kcna1, potassium voltage-gated channel, shaker-related subfamily, member 1, [RH, Score=610, Expect=0.0]; ENSMUSG00000047959, Kcna3, potassium voltage-gated channel, shaker-related subfamily, member 3, [RH, Score=607, Expect=0.0]; ENSMUSG00000042604, Kcna4, potassium voltage-gated channel, shaker-related subfamily, member 4, [RH, Score=587, Expect=0.0]} {Dmel: FBgn0003380, Sh, Shaker, [RH, Score=629, Expect=0.0]} {Celegans: WBGene00014261, shk-1, Potassium voltage-gated channel protein shk-1, [RH, Score=377, Expect=2e-124]} {Smed: dd_Smed_v6_15425_0_1, dd_Smed_v6_15425_0_1, [RH, Score=707, Expect=0.0]} {RNA1509_47579} {RNA1310_8777} {RNA815_4701} |
6. | MligTC455_28239 | 224 | 4.67 | Mlig455_019487, Mlig455_022546, Mlig455_025484, Mlig455_035873, Mlig455_060690, Mlig455_066751 | Neo: - Age: Down-Up-Down |
0.957 | - | - | 0.957 | - | - | - | Mlig455_019487 {REF} {Length: 943} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_57922} {RNA1310_17737.1} {RNA815_39121} Mlig455_022546 {REF} {Length: 1186} {NoTransDecoderORF} {RNA1509_25886} {RNA1310_11504.1} {RNA815_33924} Mlig455_025484 {REF} {Length: 3729} {NoTransDecoderORF} {RNA1509_20409, RNA1509_57922} {RNA1310_17062, RNA1509_20409, RNA1509_57922} {RNA1509_20409, RNA1509_57922, RNA815_17069.1} Mlig455_035873 {REF} {Length: 1678} {NoTransDecoderORF} {RNA1509_25886} {RNA1310_11504.1, RNA1509_25886} {RNA1509_25886, RNA815_17069.1} Mlig455_060690 {REF} {Length: 2757} {NoTransDecoderORF} {RNA1509_25886} {RNA1310_11504.1} {RNA815_33924} Mlig455_066751 {REF} {Length: 361} {NoTransDecoderORF} {RNA1509_57922} {RNA1310_17737.3} {RNA815_39121} |